Tag: DEFUSE 3
Going beyond DAWN and DEFUSE 3: New studies point to need...
A series of studies published in the Journal of NeuroInterventional Surgery is bringing attention to potential constraints in the practice-changing DAWN and DEFUSE 3 trials, when...
DEFUSE 3 shows favourable outcomes for late-window patients and triggers expanded...
The study results show that endovascular therapy, given alongside standard medical therapy, results in better functional outcome than standard medical therapy alone for ischaemic...
New ischaemic stroke guidelines widen mechanical thrombectomy window to 24 hours...
The American Heart Association and American Stroke Association released updated ischaemic stroke guidelines that were published in Stroke, and released during the International Stroke...
Two trials validate use of image-based selection for late window stroke...
With the results of the DAWN trial now published in the New England Journal of Medicine and the late time window data from the...
DEFUSE 3 terminated early with high likelihood of benefit in the...
Following an interim analysis of data from the first 182 patients enrolled in DEFUSE 3, the trial has been terminated and is no longer...
